News | September 26, 2023
Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Subscribe To Our Newsletter & Stay Updated
